Clinical Trials Consulting & Training - Accounts to registrar (filleted) - small 18.2

Clinical Trials Consulting & Training - Accounts to registrar (filleted) - small 18.2


IRIS Accounts Production v18.2.0.360 06386114 Board of Directors Board of Directors 1.4.17 31.3.18 31.3.18 false true false false true false iso4217:GBPiso4217:USDiso4217:EURxbrli:sharesxbrli:pure063861142017-03-31063861142018-03-31063861142017-04-012018-03-31063861142016-03-31063861142016-04-012017-03-31063861142017-03-3106386114ns15:EnglandWales2017-04-012018-03-3106386114ns14:PoundSterling2017-04-012018-03-3106386114ns10:Director12017-04-012018-03-3106386114ns10:Director22017-04-012018-03-3106386114ns10:PrivateLimitedCompanyLtd2017-04-012018-03-3106386114ns10:SmallEntities2017-04-012018-03-3106386114ns10:AuditExempt-NoAccountantsReport2017-04-012018-03-3106386114ns10:SmallCompaniesRegimeForDirectorsReport2017-04-012018-03-3106386114ns10:SmallCompaniesRegimeForAccounts2017-04-012018-03-3106386114ns10:FullAccounts2017-04-012018-03-3106386114ns10:CompanySecretary12017-04-012018-03-3106386114ns10:RegisteredOffice2017-04-012018-03-3106386114ns5:CurrentFinancialInstruments2018-03-3106386114ns5:CurrentFinancialInstruments2017-03-3106386114ns5:ShareCapital2018-03-3106386114ns5:ShareCapital2017-03-3106386114ns5:RetainedEarningsAccumulatedLosses2018-03-3106386114ns5:RetainedEarningsAccumulatedLosses2017-03-3106386114ns5:PlantMachinery2017-04-012018-03-3106386114ns5:PlantMachinery2017-03-3106386114ns5:PlantMachinery2018-03-3106386114ns5:PlantMachinery2017-03-3106386114ns5:CurrentFinancialInstrumentsns5:WithinOneYear2018-03-3106386114ns5:CurrentFinancialInstrumentsns5:WithinOneYear2017-03-3106386114ns10:Director112017-03-3106386114ns10:Director112016-03-3106386114ns10:Director112017-04-012018-03-3106386114ns10:Director112016-04-012017-03-3106386114ns10:Director112018-03-3106386114ns10:Director112017-03-3106386114ns10:Director222017-03-3106386114ns10:Director222016-03-3106386114ns10:Director222017-04-012018-03-3106386114ns10:Director222016-04-012017-03-3106386114ns10:Director222018-03-3106386114ns10:Director222017-03-31


REGISTERED NUMBER: 06386114 (England and Wales)















Clinical Trials Consulting
& Training Limited

Unaudited Financial Statements for the Year Ended 31st March 2018






Clinical Trials Consulting
& Training Limited (Registered number: 06386114)






Contents of the Financial Statements
for the Year Ended 31st March 2018




Page

Company Information 1

Statement of Financial Position 2

Notes to the Financial Statements 4


Clinical Trials Consulting
& Training Limited

Company Information
for the Year Ended 31st March 2018







DIRECTORS: Dr. S J Day
Mrs. N D M Day





SECRETARY: Mrs. N D M Day





REGISTERED OFFICE: 53 Portway
North Marston
Buckingham
Buckinghamshire
MK18 3PL





REGISTERED NUMBER: 06386114 (England and Wales)





ACCOUNTANTS: Courts Accountancy Services Ltd
Investment House
26 Celtic Court
Ballmoor
Buckingham
Buckinghamshire
MK18 1RQ

Clinical Trials Consulting
& Training Limited (Registered number: 06386114)

Statement of Financial Position
31st March 2018

31.3.18 31.3.17
Notes £    £    £    £   
FIXED ASSETS
Tangible assets 4 785 1,185

CURRENT ASSETS
Debtors 5 136,723 56,427
Cash at bank 321,809 395,419
458,532 451,846
CREDITORS
Amounts falling due within one year 6 60,102 72,688
NET CURRENT ASSETS 398,430 379,158
TOTAL ASSETS LESS CURRENT
LIABILITIES

399,215

380,343

CAPITAL AND RESERVES
Called up share capital 100 100
Retained earnings 399,115 380,243
SHAREHOLDERS' FUNDS 399,215 380,343

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 31st March 2018.

The members have not required the company to obtain an audit of its financial statements for the year ended 31st March 2018 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:
(a)ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the
Companies Act 2006 and
(b)preparing financial statements which give a true and fair view of the state of affairs of the company as
at the end of each financial year and of its profit or loss for each financial year in accordance with the
requirements of Sections 394 and 395 and which otherwise comply with the requirements of the
Companies Act 2006 relating to financial statements, so far as applicable to the company.

Clinical Trials Consulting
& Training Limited (Registered number: 06386114)

Statement of Financial Position - continued
31st March 2018


The financial statements have been prepared and delivered in accordance with the provisions of Part 15 of the Companies Act 2006 relating to small companies.

In accordance with Section 444 of the Companies Act 2006, the Statement of Income and Retained Earnings has not been delivered.

The financial statements were approved by the Board of Directors on 2nd August 2018 and were signed on
its behalf by:




Dr. S J Day - Director



Mrs. N D M Day - Director


Clinical Trials Consulting
& Training Limited (Registered number: 06386114)

Notes to the Financial Statements
for the Year Ended 31st March 2018

1. STATUTORY INFORMATION

Clinical Trials Consulting & Training Limited is a private company, limited by shares , registered in
England and Wales. The company's registered number and registered office address can be found on
the Company Information page.

2. ACCOUNTING POLICIES

Basis of preparing the financial statements
These financial statements have been prepared in accordance with the provisions of Section 1A "Small Entities" of Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Turnover
Turnover is measured at the fair value of the consideration received or receivable, excluding
discounts, rebates, value added tax and other sales taxes.

Tangible fixed assets
Depreciation is provided at the following annual rates in order to write off the cost less estimated residual value of each asset over its estimated useful life.
Plant and machinery etc - 25% on reducing balance

Taxation
Taxation for the year comprises current and deferred tax. Tax is recognised in the Income
Statement, except to the extent that it relates to items recognised in other comprehensive income
or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been
enacted or substantively enacted by the statement of financial position date.

Deferred tax
Deferred tax is recognised in respect of all timing differences that have originated but not reversed
at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods
different from those in which they are recognised in financial statements. Deferred tax is measured
using tax rates and laws that have been enacted or substantively enacted by the year end and that
are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is
probable that they will be recovered against the reversal of deferred tax liabilities or other future
taxable profits.

Pension costs and other post-retirement benefits
The company operates a defined contribution pension scheme. Contributions payable to the
company's pension scheme are charged to profit or loss in the period to which they relate.

Clinical Trials Consulting
& Training Limited (Registered number: 06386114)

Notes to the Financial Statements - continued
for the Year Ended 31st March 2018

3. EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2017 - 3 ) .

4. TANGIBLE FIXED ASSETS
Plant and
machinery
etc
£   
COST
At 1st April 2017 2,767
Disposals (526 )
At 31st March 2018 2,241
DEPRECIATION
At 1st April 2017 1,582
Charge for year 254
Eliminated on disposal (380 )
At 31st March 2018 1,456
NET BOOK VALUE
At 31st March 2018 785
At 31st March 2017 1,185

5. DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.18 31.3.17
£    £   
Trade debtors 45,693 56,427
Other debtors 91,030 -
136,723 56,427

6. CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR
31.3.18 31.3.17
£    £   
Bank loans and overdrafts - 561
Trade creditors 15,191 53
Taxation and social security 44,429 69,324
Other creditors 482 2,750
60,102 72,688

Clinical Trials Consulting
& Training Limited (Registered number: 06386114)

Notes to the Financial Statements - continued
for the Year Ended 31st March 2018

7. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES

The following advances and credits to directors subsisted during the years ended 31st March 2018
and 31st March 2017:

31.3.18 31.3.17
£    £   
Dr. S J Day
Balance outstanding at start of year (147 ) -
Amounts advanced 44,792 (147 )
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 44,645 (147 )

Mrs. N D M Day
Balance outstanding at start of year - -
Amounts advanced 44,792 -
Amounts repaid - -
Amounts written off - -
Amounts waived - -
Balance outstanding at end of year 44,792 -